Literature DB >> 17407429

Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia.

Louisa Degenhardt1, Amanda Roxburgh, Rebecca McKetin.   

Abstract

OBJECTIVE: To examine trends in hospital separations related to "drug-induced" psychosis for cannabis and methamphetamine, in the context of patterns of cannabis and methamphetamine use in the Australian population. DESIGN AND
SETTING: Analysis of prospectively collected data from the National Hospital Morbidity Database on hospital separations primarily attributed to drug-induced psychosis (July 1993 - June 2004), and specifically for cannabis and amphetamines (1999-2004). Calculation of Australian population-adjusted rates of drug-induced psychosis hospital separations using estimated resident population data from the Australian Bureau of Statistics (at 30 June each year) and data on cannabis and methamphetamine use from the 2004 National Drug Strategy Household Survey. MAIN OUTCOME MEASURES: Number of hospital separations due to drug-induced psychosis, and standardised (age-specific) rates per million population and per million users.
RESULTS: There have been notable increases in hospital separations due to drug-induced psychosis, which appear to have been driven by amphetamine-related rather than cannabis-related episodes. The rate of hospital separations was higher for amphetamine users than for cannabis users in all age groups, and the rate increased among older amphetamine users.
CONCLUSIONS: The risk of hospitalisation for a drug-induced psychotic episode associated with amphetamine use appears to be greater than that for cannabis use in all age groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407429     DOI: 10.5694/j.1326-5377.2007.tb00933.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  11 in total

1.  An intercalation mechanism as a mode of action exerted by psychotropic drugs: results of altered phospholipid substrate availabilities in membranes?

Authors:  Ramadhan Oruch; Anders Lund; Ian F Pryme; Holm Holmsen
Journal:  J Chem Biol       Date:  2010-01-27

2.  Association between psychiatric symptoms and craving in methamphetamine users.

Authors:  Helenna Nakama; Linda Chang; Christine Cloak; Caroline Jiang; Daniel Alicata; William Haning
Journal:  Am J Addict       Date:  2008 Sep-Oct

3.  Polysubstance-induced relapse of schizoaffective disorder refractory to high-dose antipsychotic medications: a case report.

Authors:  Murray G Tucker; Sebastian Kekulawala; Michelle Kent; Sam Mostafa; Richard Harvey
Journal:  J Med Case Rep       Date:  2016-09-06

4.  Chemical and biological studies of β-carotene after exposure to Cannabis sativa smoke.

Authors:  Dulciana S do Monte; Jonh A Bezerra Tenório; Isla V G A Bastos; Fábio de S Mendonça; Joaquim E Neto; Teresinha G da Silva; Clécio S Ramos
Journal:  Toxicol Rep       Date:  2016-06-03

5.  Exploring How People Affected by Methamphetamine Exchange Social Support Through Online Interactions on Facebook: Content Analysis.

Authors:  Daniel Ellway; Rachel Reilly; Amanda Le Couteur; James Ward
Journal:  JMIR Ment Health       Date:  2019-10-01

6.  Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015-2019.

Authors:  Russell C Callaghan; Marcos Sanches; Robin M Murray; Sarah Konefal; Bridget Maloney-Hall; Stephen J Kish
Journal:  Can J Psychiatry       Date:  2022-01-12       Impact factor: 5.321

7.  Thiopentone sedation for sedation of acutely agitated, violent, intoxicated patients: evaluation of 2 cases.

Authors:  Marten C Howes; Werner Janse van Rensburg
Journal:  Int J Emerg Med       Date:  2009-02-24

Review 8.  Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?

Authors:  Jørgen G Bramness; Øystein Hoel Gundersen; Joar Guterstam; Eline Borger Rognli; Maija Konstenius; Else-Marie Løberg; Sigrid Medhus; Lars Tanum; Johan Franck
Journal:  BMC Psychiatry       Date:  2012-12-05       Impact factor: 3.630

Review 9.  Does Cannabidiol Protect Against Adverse Psychological Effects of THC?

Authors:  Raymond J M Niesink; Margriet W van Laar
Journal:  Front Psychiatry       Date:  2013-10-16       Impact factor: 4.157

10.  Methamphetamine-Associated Psychosis and Treatment With Haloperidol and Risperidone: A Pilot Study.

Authors:  Mercede Samiei; Mohammad Vahidi; Omid Rezaee; Azadeh Yaraghchi; Reza Daneshmand
Journal:  Iran J Psychiatry Behav Sci       Date:  2016-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.